Downregulation of m6A demethylase ALKBH5 promotes AuNP-induced neural stem cell quiescence via regulating ID4 expression

被引:2
|
作者
Huang, Xiaofeng [1 ,2 ]
Yang, Renjun [1 ,2 ]
Qi, Zijuan [1 ,3 ]
Wang, Xudong [1 ,2 ]
Yin, Nuoya [1 ,2 ]
Faiola, Francesco [1 ,2 ]
Liu, Sijin [1 ,2 ]
Gao, Ming [1 ,2 ]
机构
[1] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China
[2] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100085, Peoples R China
[3] Shandong First Med Univ, Dept Orthoped Surg, Affiliated Hosp 1, Jinan 250014, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
GOLD NANOPARTICLES; IN-VITRO; SIZE; TOXICITY; GROWTH;
D O I
10.1039/d2en00734g
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Gold nanoparticles (AuNPs) have been widely used in the biomedical field due to their unique physical and chemical properties, and thus pose a potential risk to human health. However, at present, the toxic effects and related mechanisms of AuNPs are still largely unknown; in particular, their long-term neurotoxicity risk has been underestimated. In this study, we found that AuNP treatment induced the quiescence of neural stem cells (NSCs) by upregulating the expression of inhibitors of DNA binding/differentiation proteins 4 (ID4) in a size-effect dependent manner. Further mechanism analysis showed that AuNP treatment enhanced the N6-methyladenosine (m(6)A) modification and thereafter the mRNA stability of ID4 via downregulation of the expression of demethylase ALKBH5, leading to increased ID4 expression in an m(6)A reader IGF2BP3 dependent manner and subsequent NSC quiescence. In summary, our findings demonstrate that m(6)A modification-dependent ID4 upregulation is indispensable for NSC quiescence and neurotoxicity induced by low-dose AuNPs, providing novel insight for recognizing the health risk of AuNPs and a new strategy for preventing AuNP-induced disorder of stem cell development.
引用
收藏
页码:843 / 854
页数:12
相关论文
共 50 条
  • [31] The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA
    Li, Xiao-Cui
    Jin, Feng
    Wang, Bei-Ying
    Yin, Xiang-Jie
    Hong, Wei
    Tian, Fu-Ju
    THERANOSTICS, 2019, 9 (13): : 3853 - 3865
  • [32] Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response
    Yu, Fang
    Wei, Jiangbo
    Cui, Xiaolong
    Yu, Chunjie
    Ni, Wei
    Bungert, Jorg
    Wu, Lizi
    He, Chuan
    Qian, Zhijian
    NUCLEIC ACIDS RESEARCH, 2021, 49 (10) : 5779 - 5797
  • [33] m6A demethylase ALKBH5 drives denervation-induced muscle atrophy by targeting HDAC4 to activate FoxO3 signalling
    Liu, Yuantong
    Zhou, Tianjian
    Wang, Qinghe
    Fu, Runhan
    Zhang, Zengfu
    Chen, Nandi
    Li, Zhizhong
    Gao, Guoyong
    Peng, Songlin
    Yang, Dazhi
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (02) : 1210 - 1223
  • [34] Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay
    Gu, Ning
    Shen, Youcheng
    He, Yuanjie
    Li, Chaofu
    Xiong, Weidong
    Hu, Yiqing
    Qiu, Zhimei
    Peng, Fengli
    Han, Weiyu
    Li, Chaozhong
    Long, Xianping
    Zhao, Ranzun
    Zhao, Yongchao
    Shi, Bei
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2024, 194 : 16 - 31
  • [35] ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner
    Li, Luyao
    Zhou, Mei
    Chen, Biyun
    Wang, Qin
    Pan, Shuya
    Hou, Yaxuan
    Xia, Jiamin
    Zhou, Xue
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2021, 224
  • [36] ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells
    Luo, Jing
    Yu, Hongmei
    Yuan, Zhen
    Ye, Tao
    Hu, Bo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (07): : 2265 - 2276
  • [37] ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells
    Jing Luo
    Hongmei Yu
    Zhen Yuan
    Tao Ye
    Bo Hu
    Clinical and Translational Oncology, 2023, 25 : 2265 - 2276
  • [38] m6A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer
    Kazuo Tsuchiya
    Katsuhiro Yoshimura
    Yuji Iwashita
    Yusuke Inoue
    Tsutomu Ohta
    Hirofumi Watanabe
    Hidetaka Yamada
    Akikazu Kawase
    Masayuki Tanahashi
    Hiroshi Ogawa
    Kazuhito Funai
    Kazuya Shinmura
    Takafumi Suda
    Haruhiko Sugimura
    Cancer Gene Therapy, 2022, 29 : 1355 - 1372
  • [39] m6A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer
    Tsuchiya, Kazuo
    Yoshimura, Katsuhiro
    Iwashita, Yuji
    Inoue, Yusuke
    Ohta, Tsutomu
    Watanabe, Hirofumi
    Yamada, Hidetaka
    Kawase, Akikazu
    Tanahashi, Masayuki
    Ogawa, Hiroshi
    Funai, Kazuhito
    Shinmura, Kazuya
    Suda, Takafumi
    Sugimura, Haruhiko
    CANCER GENE THERAPY, 2022, 29 (10) : 1355 - 1372
  • [40] ALKBH5 MODULATES HEMATOPOIETIC STEM AND PROGENITOR CELL ENERGY METABOLISM THROUGH M6A MODIFICATION -MEDIATED RNA STABILITY CONTROL
    Gao, Yimeng
    Biancon, Giulia
    Flavell, Richard
    Gbyli, Rana
    Halene, Stephanie
    Kibbey, Richard
    Li, Hua-Bing
    Li, Yaping
    Liu, Chengyang
    Liu, Wei
    Nelakanti, Raman
    Patel, Amisha
    Qi, Zhihong
    Simon, Matthew
    Slavoff, Sarah
    Song, Yuanbin
    Tebaldi, Toma
    Vasic, Radovan
    Xiao, Andrew
    Zheng, Shu-Jian
    Zimmer, Joshua
    EXPERIMENTAL HEMATOLOGY, 2023, 124 : S82 - S82